Data:
{
"symbol": "BIIB",
"price": 228.69,
"marketCap": 33789861803,
"beta": 0.171,
"lastDividend": 0,
"range": "135.39-230.49",
"change": 1.09,
"changePercentage": 0.47891,
"volume": 1313729,
"averageVolume": 1087980,
"companyName": "Biogen Inc.",
"currency": "USD",
"cik": "0000875045",
"isin": "US09062X1037",
"cusip": "09062X103",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Drug Manufacturers - General",
"website": "https://www.biogen.com",
"description": "Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy (SMA), Biogen provides SPINRAZA, while FUMADERM is available for the treatment of plaque psoriasis. Among its other key offerings is ADUHELM, specifically developed for Alzheimer's disease. The company also markets a selection of biosimilar drugs, including BENEPALI (an etanercept biosimilar akin to ENBREL), IMRALDI (an adalimumab biosimilar comparable to HUMIRA), and FLIXABI (an infliximab biosimilar referencing REMICADE). Further extending its therapeutic reach, Biogen supplies RITUXAN, prescribed for conditions like non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, certain types of ANCA-associated vasculitis, and pemphigus vulgaris. RITUXAN HYCELA targets non-Hodgkin's lymphoma and CLL, and GAZYVA is utilized for CLL and follicular lymphoma. OCREVUS addresses both relapsing and primary progressive forms of MS, complementing the company's broader efforts in anti-CD20 therapies. The company maintains a robust research and development pipeline, featuring numerous investigational therapies. These candidates are designed to tackle a wide spectrum of conditions, including multiple sclerosis and neuroimmunological disorders (e.g., BIIB135, BIIB061, BIIB091, BIIB107), Alzheimer's disease and other forms of dementia (e.g., Aducanumab, Lecanemab, BIIB076, BIIB080), neuromuscular disorders (e.g., BIIB067, BIIB078, BIIB105, BIIB100, BIIB110), Parkinson's disease and related movement disorders (e.g., BIIB124, BIIB094, BIIB118, BIIB101, BIIB122), neuropsychiatric conditions (e.g., BIIB125, BIIB104), immunology-related illnesses (e.g., Dapirolizumab pegol, BIIB059), acute neurological events (e.g., BIIB093, BIIB131), and neuropathic pain (e.g., BIIB074). Additionally, several biosimilar candidates, such as BYOOVIZ, BIIB800, and SB15, are progressing through various developmental stages. Biogen actively engages in strategic collaborations and licensing arrangements with various partners, including Acorda Therapeutics, Inc., Alkermes Pharma Ireland Limited, Denali Therapeutics Inc., Eisai Co., Ltd., Genentech, Inc., Neurimmune SubOne AG, Ionis Pharmaceuticals, Inc., Samsung Bioepis Co., Ltd., Sangamo Therapeutics, Inc., and Sage Therapeutics, Inc. Established in 1978, Biogen Inc. maintains its corporate headquarters in Cambridge, Massachusetts.",
"ceo": "Christopher A. Viehbacher",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "7500",
"phone": "617 679 2000",
"address": "225 Binney Street",
"city": "Cambridge",
"state": "MA",
"zip": "02142",
"image": "https://images.financialmodelingprep.com/symbol/BIIB.png",
"ipoDate": "1991-09-17",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "BIIB",
"name": "Biogen Inc.",
"price": 227.07,
"changePercentage": -0.70838,
"change": -1.62,
"volume": 1125094,
"dayLow": 224.45,
"dayHigh": 229.41,
"yearHigh": 230.49,
"yearLow": 136.94,
"marketCap": 33550500326,
"priceAvg50": 213.4114,
"priceAvg200": 194.21255,
"exchange": "NASDAQ",
"open": 227.02,
"previousClose": 228.69,
"timestamp": 1790712001,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-19",
"v": 220.3707,
"c": 221.56
},
{
"t": "2026-08-20",
"v": 216.2785,
"c": 214.35
},
{
"t": "2026-08-21",
"v": 217.2836,
"c": 216.78
},
{
"t": "2026-08-24",
"v": 216.788,
"c": 218.12
},
{
"t": "2026-08-25",
"v": 220.9264,
"c": 220.77
},
{
"t": "2026-08-26",
"v": 220.7504,
"c": 221.07
},
{
"t": "2026-08-27",
"v": 220.9899,
"c": 221.5
},
{
"t": "2026-08-28",
"v": 218.2049,
"c": 218.5
},
{
"t": "2026-08-31",
"v": 217.1045,
"c": 216.65
},
{
"t": "2026-09-01",
"v": 215.911,
"c": 216.04
},
{
"t": "2026-09-02",
"v": 222.3754,
"c": 222.67
},
{
"t": "2026-09-03",
"v": 224.2411,
"c": 224.51
},
{
"t": "2026-09-04",
"v": 220.8864,
"c": 220.83
},
{
"t": "2026-09-08",
"v": 213.4241,
"c": 212.5
},
{
"t": "2026-09-09",
"v": 211.3101,
"c": 210.73
},
{
"t": "2026-09-10",
"v": 215.1603,
"c": 215.43
},
{
"t": "2026-09-11",
"v": 217.5467,
"c": 217.15
},
{
"t": "2026-09-14",
"v": 217.5461,
"c": 217.36
},
{
"t": "2026-09-15",
"v": 215.7075,
"c": 216.17
},
{
"t": "2026-09-16",
"v": 216.2715,
"c": 216.01
},
{
"t": "2026-09-17",
"v": 218.161,
"c": 219.05
},
{
"t": "2026-09-18",
"v": 216.0756,
"c": 215.5
},
{
"t": "2026-09-21",
"v": 219.7693,
"c": 219.07
},
{
"t": "2026-09-22",
"v": 224.8501,
"c": 225.36
},
{
"t": "2026-09-23",
"v": 226.3885,
"c": 227.53
},
{
"t": "2026-09-24",
"v": 226.7059,
"c": 226.36
},
{
"t": "2026-09-25",
"v": 226.9785,
"c": 227.6
},
{
"t": "2026-09-28",
"v": 228.6234,
"c": 228.69
},
{
"t": "2026-09-29",
"v": 226.8001,
"c": 227.07
}
],
"vwap_summary": {
"days": 29,
"days_above": 16,
"days_below": 13,
"pct_days_above": 55,
"position": "above",
"gap_pct": 0.12,
"streak_days": 3
}
}
Data:
{
"volume": 1125094,
"avgVolume": 1087980,
"short_ratio": [
{
"symbol": "BIIB",
"file_date": "2026-09-28",
"date": "20260928",
"short_volume": 315067,
"short_exempt_volume": 0,
"total_volume": 501596,
"short_volume_ratio": 0.6281,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 216.04,
"vah": 226.16,
"val": 213.47,
"profile": [
{
"price": 209.86,
"volume": 4948
},
{
"price": 210.21,
"volume": 30689
},
{
"price": 210.55,
"volume": 3812
},
{
"price": 210.89,
"volume": 129149
},
{
"price": 211.24,
"volume": 81748
},
{
"price": 211.58,
"volume": 96746
},
{
"price": 211.92,
"volume": 85939
},
{
"price": 212.27,
"volume": 60083
},
{
"price": 212.61,
"volume": 124379
},
{
"price": 212.95,
"volume": 47878
},
{
"price": 213.3,
"volume": 54839
},
{
"price": 213.64,
"volume": 83391
},
{
"price": 213.98,
"volume": 170889
},
{
"price": 214.32,
"volume": 184570
},
{
"price": 214.67,
"volume": 160544
},
{
"price": 215.01,
"volume": 150789
},
{
"price": 215.35,
"volume": 322336
},
{
"price": 215.7,
"volume": 619192
},
{
"price": 216.04,
"volume": 679003
},
{
"price": 216.38,
"volume": 261194
},
{
"price": 216.73,
"volume": 293347
},
{
"price": 217.07,
"volume": 270259
},
{
"price": 217.41,
"volume": 604501
},
{
"price": 217.76,
"volume": 306044
},
{
"price": 218.1,
"volume": 306486
},
{
"price": 218.44,
"volume": 289842
},
{
"price": 218.78,
"volume": 119970
},
{
"price": 219.13,
"volume": 322849
},
{
"price": 219.47,
"volume": 199866
},
{
"price": 219.81,
"volume": 78898
},
{
"price": 220.16,
"volume": 133156
},
{
"price": 220.5,
"volume": 142429
},
{
"price": 220.84,
"volume": 392149
},
{
"price": 221.19,
"volume": 112357
},
{
"price": 221.53,
"volume": 132773
},
{
"price": 221.87,
"volume": 72121
},
{
"price": 222.21,
"volume": 142824
},
{
"price": 222.56,
"volume": 181205
},
{
"price": 222.9,
"volume": 205729
},
{
"price": 223.24,
"volume": 107697
},
{
"price": 223.59,
"volume": 130924
},
{
"price": 223.93,
"volume": 126079
},
{
"price": 224.27,
"volume": 213713
},
{
"price": 224.62,
"volume": 214431
},
{
"price": 224.96,
"volume": 320800
},
{
"price": 225.3,
"volume": 182952
},
{
"price": 225.65,
"volume": 419314
},
{
"price": 225.99,
"volume": 316187
},
{
"price": 226.33,
"volume": 202017
},
{
"price": 226.67,
"volume": 510463
},
{
"price": 227.02,
"volume": 607282
},
{
"price": 227.36,
"volume": 233246
},
{
"price": 227.7,
"volume": 559473
},
{
"price": 228.05,
"volume": 273951
},
{
"price": 228.39,
"volume": 258750
},
{
"price": 228.73,
"volume": 204909
},
{
"price": 229.08,
"volume": 75450
},
{
"price": 229.42,
"volume": 65412
},
{
"price": 229.76,
"volume": 65922
},
{
"price": 230.11,
"volume": 65272
}
],
"sessions": 20
}
}
Data:
{
"symbol": "BIIB",
"marketCap": 33550500326,
"enterpriseValueTTM": 40620600326,
"evToSalesTTM": 4.083334203801807,
"evToOperatingCashFlowTTM": 14.109764259265692,
"evToFreeCashFlowTTM": 13.682958980698624,
"evToEBITDATTM": 24.310611243042672,
"netDebtToEBITDATTM": 4.231312466335508,
"currentRatioTTM": 1.8650787572438794,
"incomeQualityTTM": 6.893917624521073,
"grahamNumberTTM": 127.41183832281654,
"grahamNetNetTTM": -63.28537576167908,
"taxBurdenTTM": 0.9751156001868286,
"interestBurdenTTM": 0.7694519317160826,
"workingCapitalTTM": 3388600000,
"investedCapitalTTM": 27135600000,
"returnOnAssetsTTM": 0.026026098121957452,
"operatingReturnOnAssetsTTM": 0.04132877048288362,
"returnOnTangibleAssetsTTM": 0.0721185035494067,
"returnOnEquityTTM": 0.045161916608079604,
"returnOnInvestedCapitalTTM": 0.04282571594669228,
"returnOnCapitalEmployedTTM": 0.04516587088872717,
"earningsYieldTTM": 0.02489960787744401,
"freeCashFlowYieldTTM": 0.0884845224707246,
"capexToOperatingCashFlowTTM": 0.031192469345930736,
"capexToDepreciationTTM": 0.2231610337972167,
"capexToRevenueTTM": 0.00902703083062757,
"salesGeneralAndAdministrativeToRevenueTTM": 0.2608389710391138,
"researchAndDevelopementToRevenueTTM": 0.19576996139888822,
"stockBasedCompensationToRevenueTTM": 0.013560650991666583,
"intangiblesToTotalAssetsTTM": 0.6391203804703521,
"averageReceivablesTTM": 1838000000,
"averagePayablesTTM": 381200000,
"averageInventoryTTM": 2166650000,
"daysOfSalesOutstandingTTM": 69.18485308457062,
"daysOfPayablesOutstandingTTM": 45.890583657587555,
"daysOfInventoryOutstandingTTM": 270.9010116731518,
"operatingCycleTTM": 340.08586475772245,
"cashConversionCycleTTM": 294.1952811001349,
"freeCashFlowToEquityTTM": 2963100000,
"freeCashFlowToFirmTTM": 3241112922.933209,
"tangibleAssetValueTTM": -1659200000,
"netCurrentAssetValueTTM": -5932900000,
"grossProfitMarginTTM": 0.6770675216879944,
"ebitMarginTTM": 0.11188290996089627,
"ebitdaMarginTTM": 0.167965098161421,
"operatingProfitMarginTTM": 0.12789633993104071,
"pretaxProfitMarginTTM": 0.08608852119542817,
"continuousOperationsProfitMarginTTM": 0.08394626001467646,
"netProfitMarginTTM": 0.08394626001467646,
"bottomLineProfitMarginTTM": 0.08394626001467646,
"receivablesTurnoverTTM": 5.275721255833687,
"payablesTurnoverTTM": 7.953701411240406,
"inventoryTurnoverTTM": 1.3473556180010904,
"fixedAssetTurnoverTTM": 3.070529045002778,
"assetTurnoverTTM": 0.31003284860346686,
"quickRatioTTM": 1.256388654872227,
"solvencyRatioTTM": 0.10522177571646549,
"cashRatioTTM": 0.32804881162084193,
"priceToEarningsRatioTTM": 39.97711267605634,
"priceToEarningsGrowthRatioTTM": -0.8708707118228042,
"forwardPriceToEarningsGrowthRatioTTM": -2.3673591873780504,
"priceToEarningsDilutedRatioTTM": 40.18938053097345,
"priceToEarningsDilutedGrowthRatioTTM": -0.872018028912219,
"priceToBookRatioTTM": 1.7794057194397284,
"priceToSalesRatioTTM": 3.372621390042119,
"priceToFreeCashFlowRatioTTM": 11.301411502004244,
"priceToOperatingCashFlowRatioTTM": 11.6496714022717,
"debtToAssetsRatioTTM": 0.26039218863949437,
"debtToEquityRatioTTM": 0.44328841256366724,
"debtToCapitalRatioTTM": 0.30713778944311493,
"longTermDebtToCapitalRatioTTM": 0.27891255360907174,
"financialLeverageRatioTTM": 1.7023875212224109,
"workingCapitalTurnoverRatioTTM": 2.0767841671798832,
"operatingCashFlowRatioTTM": 0.7349569834826785,
"operatingCashFlowSalesRatioTTM": 0.28939776234180076,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0311924693459307,
"debtServiceCoverageRatioTTM": 1.5206388274336282,
"interestCoverageRatioTTM": 4.467345505617978,
"shortTermOperatingCashFlowCoverageRatioTTM": 3.598625,
"operatingCashFlowCoverageRatioTTM": 0.34456798841426195,
"capitalExpenditureCoverageRatioTTM": 32.05902004454343,
"dividendPaidAndCapexCoverageRatioTTM": 32.05902004454343,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 67.35206499661476,
"netIncomePerShareTTM": 5.6539539607312115,
"interestDebtPerShareTTM": 58.496276235612726,
"cashPerShareTTM": 8.700067704807042,
"bookValuePerShareTTM": 127.61002031144211,
"tangibleBookValuePerShareTTM": -11.233581584292486,
"shareholdersEquityPerShareTTM": 127.61002031144211,
"operatingCashFlowPerShareTTM": 19.491536899119836,
"capexPerShareTTM": 0.6079891672308734,
"freeCashFlowPerShareTTM": 20.099526066350712,
"netIncomePerEBTTTM": 0.9751156001868286,
"ebtPerEbitTTM": 0.6731116874950877,
"priceToFairValueTTM": 1.7794057194397284,
"debtToMarketCapTTM": 0.2411379836780083,
"effectiveTaxRateTTM": 0.024884399813171414,
"enterpriseValueMultipleTTM": 24.310611243042672,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 9810600000
}
],
"dcf": {
"symbol": "BIIB",
"date": "2026-09-29",
"dcf": 509.273457538368,
"Stock Price": 226.7743
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "BIIB",
"reportedCurrency": "USD",
"cik": "0000875045",
"filingDate": "2026-02-06",
"acceptedDate": "2026-02-06 07:36:07",
"fiscalYear": "2025",
"period": "FY",
"revenue": 9810600000,
"costOfRevenue": 2897000000,
"grossProfit": 6913600000,
"researchAndDevelopmentExpenses": 1954700000,
"generalAndAdministrativeExpenses": 2433700000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 2433700000,
"otherExpenses": 647700000,
"operatingExpenses": 5036100000,
"costAndExpenses": 7933100000,
"netInterestIncome": -158200000,
"interestIncome": 87800000,
"interestExpense": 246000000,
"depreciationAndAmortization": 935400000,
"ebitda": 3100600000,
"ebit": 2165200000,
"nonOperatingIncomeExcludingInterest": -287700000,
"operatingIncome": 1877500000,
"totalOtherIncomeExpensesNet": -476000000,
"incomeBeforeTax": 1401500000,
"incomeTaxExpense": 108111000,
"netIncomeFromContinuingOperations": 1293389000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 1293389000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 1293389000,
"eps": 8.85,
"epsDiluted": 8.83,
"weightedAverageShsOut": 146700000,
"weightedAverageShsOutDil": 146700000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "BIIB",
"reportedCurrency": "USD",
"cik": "0000875045",
"filingDate": "2026-02-06",
"acceptedDate": "2026-02-06 07:36:07",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 3008500000,
"shortTermInvestments": 807200000,
"cashAndShortTermInvestments": 3815700000,
"netReceivables": 1867000000,
"accountsReceivables": 1867000000,
"otherReceivables": 0,
"inventory": 2168100000,
"prepaids": 0,
"otherCurrentAssets": 1123300000,
"totalCurrentAssets": 8974100000,
"propertyPlantEquipmentNet": 3320800000,
"goodwill": 6491100000,
"intangibleAssets": 9178500000,
"goodwillAndIntangibleAssets": 15669600000,
"longTermInvestments": 750600000,
"taxAssets": 292500000,
"otherNonCurrentAssets": 431900000,
"totalNonCurrentAssets": 20465400000,
"otherAssets": 0,
"totalAssets": 29439500000,
"totalPayables": 546800000,
"accountPayables": 432000000,
"otherPayables": 114800000,
"accruedExpenses": 0,
"shortTermDebt": 80400000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 114800000,
"deferredRevenue": 0,
"otherCurrentLiabilities": 2722200000,
"totalCurrentLiabilities": 3349400000,
"longTermDebt": 6577200000,
"capitalLeaseObligationsNonCurrent": 290400000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 507600000,
"otherNonCurrentLiabilities": 458100000,
"totalNonCurrentLiabilities": 7833300000,
"otherLiabilities": 0,
"capitalLeaseObligations": 290400000,
"totalLiabilities": 11182700000,
"treasuryStock": -2977100000,
"preferredStock": 0,
"commonStock": 100000,
"retainedEarnings": 20552700000,
"additionalPaidInCapital": 863100000,
"accumulatedOtherComprehensiveIncomeLoss": -182000000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 18256800000,
"totalEquity": 18256800000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 29439500000,
"totalInvestments": 1557800000,
"totalDebt": 6948000000,
"netDebt": 3939500000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "BIIB",
"reportedCurrency": "USD",
"cik": "0000875045",
"filingDate": "2026-02-06",
"acceptedDate": "2026-02-06 07:36:07",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 1292900000,
"depreciationAndAmortization": 779900000,
"deferredIncomeTax": 361600000,
"stockBasedCompensation": 290800000,
"changeInWorkingCapital": -1057599999,
"accountsReceivables": 42100000,
"inventory": -64700000,
"accountsPayables": 0,
"otherWorkingCapital": -1035000000,
"otherNonCashItems": 536999999,
"netCashProvidedByOperatingActivities": 2204600000,
"investmentsInPropertyPlantAndEquipment": -153800000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -1258300000,
"salesMaturitiesOfInvestments": 79700000,
"otherInvestingActivities": -38700000,
"netCashProvidedByInvestingActivities": -1371100000,
"netDebtIssuance": -16899999,
"longTermNetDebtIssuance": -16899999,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -10000000,
"netCommonStockIssuance": -10000000,
"commonStockIssuance": -10000000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -275000000,
"netCashProvidedByFinancingActivities": -301900000,
"effectOfForexChangesOnCash": 101900000,
"netChangeInCash": 633500000,
"cashAtEndOfPeriod": 3008500000,
"cashAtBeginningOfPeriod": 2375000000,
"operatingCashFlow": 2204600000,
"capitalExpenditure": -153800000,
"freeCashFlow": 2050800000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 227.07,
"rsi": 61.011232201781176,
"sma20": 220.2814999999995,
"sma50": 213.9538000000004,
"sma200": 194.46015000000006,
"adx": 25.47264412032462,
"atr": 5.49,
"atr_pct": 2.42,
"atr_expansion_pct": -5.1,
"di_plus": 29.7,
"di_minus": 4.7,
"high_52w": 228.69,
"low_52w": 135.67,
"structure": {
"ema8": 225.09922887826838,
"ema21": 221.03037633308873,
"ema50": 215.19339660285945,
"ema200": 195.2146310771276,
"ema10": 224.25803685496064,
"ema20": 221.27325649743452,
"ema10_slope_pct": 2.56,
"ema20_slope_pct": 1.85,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 2.7,
"_no_bars": false,
"macd": {
"macd": 3.65,
"signal": 2.882,
"histogram": 0.768
},
"bollinger": {
"mid": 220.28,
"upper": 231.07,
"lower": 209.49,
"width_pct": 9.8
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 5.0,
"ret_3d": 0.31,
"ret_5d": 0.76,
"roc10_accel": -1.01,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 1.13,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 0.86,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 248810146.2
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.4,
"iv_rank": 49.0
}
}
}
}
Data:
{
"prior_day": {
"high": 229.41,
"low": 224.45,
"close": 227.07,
"date": "2026-09-29"
},
"woodie_pivots": {
"PP": 227.0,
"R1": 229.55,
"S1": 224.59,
"R2": 231.96,
"S2": 222.04
},
"swing": {
"high_20d": 230.49,
"low_20d": 208.93,
"high_60d": 230.49,
"low_60d": 186.03
},
"orb": {
"high": 229.41,
"low": 227.02,
"date": "2026-09-29"
},
"vwap": 226.69,
"volume_profile": {
"poc": 216.04,
"vah": 226.16,
"val": 213.47,
"sessions": 20
},
"intraday": {
"h1_trend": "up",
"h1_last": 227.03,
"h1_ema9": 226.9,
"h1_ema21": 226.78,
"m15_trend": "up",
"m15_last": 227.34,
"m15_ema9": 227.03,
"m15_ema21": 226.89,
"rvol_intraday": 1.12,
"as_of_et": "2026-09-29 15:55"
},
"premarket": {
"date": "2026-09-28",
"high": 225,
"low": 225,
"last": 225,
"volume": 135,
"gap_pct": -1.14,
"path": "07:30 225.00",
"bars": 1,
"last_bar_et": "07:30"
},
"recent_daily": [
{
"d": "2026-08-25",
"o": 218.93,
"h": 222.85,
"l": 218,
"c": 220.77,
"v": 495435.926706
},
{
"d": "2026-08-26",
"o": 219.34,
"h": 222,
"l": 218.6907,
"c": 221.07,
"v": 647334.323797
},
{
"d": "2026-08-27",
"o": 219.39,
"h": 222.11,
"l": 217.53,
"c": 221.5,
"v": 497524.482724
},
{
"d": "2026-08-28",
"o": 221.17,
"h": 222,
"l": 216.78,
"c": 218.5,
"v": 517484.632682
},
{
"d": "2026-08-31",
"o": 216.47,
"h": 218.89,
"l": 213.58,
"c": 216.65,
"v": 831004.074002
},
{
"d": "2026-09-01",
"o": 218.11,
"h": 219.3,
"l": 213.6,
"c": 216.04,
"v": 785496.6182
},
{
"d": "2026-09-02",
"o": 218.2,
"h": 225.59,
"l": 216.97,
"c": 222.67,
"v": 1268282.236871
},
{
"d": "2026-09-03",
"o": 225.44,
"h": 225.8,
"l": 221.23,
"c": 224.51,
"v": 550745.820147
},
{
"d": "2026-09-04",
"o": 221.15,
"h": 223.82,
"l": 219.82,
"c": 220.83,
"v": 465108.427946
},
{
"d": "2026-09-08",
"o": 215.45,
"h": 217.2803,
"l": 210.54,
"c": 212.5,
"v": 617829.995721
},
{
"d": "2026-09-09",
"o": 210.5,
"h": 213.48,
"l": 209,
"c": 210.73,
"v": 694669.268301
},
{
"d": "2026-09-10",
"o": 209.92,
"h": 216.7,
"l": 208.9279,
"c": 215.43,
"v": 936643.007464
},
{
"d": "2026-09-11",
"o": 216.75,
"h": 219.76,
"l": 214.7125,
"c": 217.15,
"v": 1075556.473458
},
{
"d": "2026-09-14",
"o": 221,
"h": 222.245,
"l": 215.56,
"c": 217.36,
"v": 629931.85991
},
{
"d": "2026-09-15",
"o": 216.71,
"h": 216.71,
"l": 213.54,
"c": 216.17,
"v": 756047.27344
},
{
"d": "2026-09-16",
"o": 216.41,
"h": 218.29,
"l": 214.81,
"c": 216.01,
"v": 606493.14189
},
{
"d": "2026-09-17",
"o": 217.68,
"h": 219.41,
"l": 215.33,
"c": 219.05,
"v": 836707.018465
},
{
"d": "2026-09-18",
"o": 219.05,
"h": 220.17,
"l": 215.26,
"c": 215.5,
"v": 2636086.806861
},
{
"d": "2026-09-21",
"o": 216.14,
"h": 221.92,
"l": 214.59,
"c": 219.07,
"v": 928562.258245
},
{
"d": "2026-09-22",
"o": 219.22,
"h": 226.43,
"l": 219,
"c": 225.36,
"v": 1112343.334753
},
{
"d": "2026-09-23",
"o": 226.94,
"h": 229.19,
"l": 222.355,
"c": 227.53,
"v": 1494492.304524
},
{
"d": "2026-09-24",
"o": 226.8,
"h": 228.72,
"l": 224.305,
"c": 226.36,
"v": 1034741.769035
},
{
"d": "2026-09-25",
"o": 228.27,
"h": 228.92,
"l": 223.76,
"c": 227.6,
"v": 958030.977629
},
{
"d": "2026-09-28",
"o": 225.87,
"h": 230.49,
"l": 225.51,
"c": 228.69,
"v": 1332340.164021
},
{
"d": "2026-09-29",
"o": 227.02,
"h": 229.41,
"l": 224.45,
"c": 227.07,
"v": 1161174.422498
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 1.33,
"etf_rvol": 0.8,
"rs_5d": 3.06,
"leading": true
}
Data:
{
"estimates": [
{
"symbol": "BIIB",
"date": "2030-12-31",
"revenueLow": 10767519675,
"revenueHigh": 11786925270,
"revenueAvg": 11382686667,
"ebitdaLow": 3932311872,
"ebitdaHigh": 4330872480,
"ebitdaAvg": 4172826007,
"ebitLow": 3430550626,
"ebitHigh": 3829111234,
"ebitAvg": 3671064761,
"netIncomeLow": 2798594452,
"netIncomeHigh": 3149041683,
"netIncomeAvg": 3010074239,
"sgaExpenseLow": 2648790050,
"sgaExpenseHigh": 2899561953,
"sgaExpenseAvg": 2800120000,
"epsAvg": 20.51857,
"epsHigh": 21.46586,
"epsLow": 19.07699,
"numAnalystsRevenue": 14,
"numAnalystsEps": 4
},
{
"symbol": "BIIB",
"date": "2029-12-31",
"revenueLow": 10556136577,
"revenueHigh": 11555529661,
"revenueAvg": 11159226888,
"ebitdaLow": 3981536721,
"ebitdaHigh": 4379935494,
"ebitdaAvg": 4221952420,
"ebitLow": 3429259279,
"ebitHigh": 3827658052,
"ebitAvg": 3669674978,
"netIncomeLow": 2797458994,
"netIncomeHigh": 3147763926,
"netIncomeAvg": 3008852228,
"sgaExpenseLow": 2596790196,
"sgaExpenseHigh": 2842639058,
"sgaExpenseAvg": 2745149305,
"epsAvg": 20.51024,
"epsHigh": 21.45715,
"epsLow": 19.06925,
"numAnalystsRevenue": 24,
"numAnalystsEps": 4
},
{
"symbol": "BIIB",
"date": "2028-12-31",
"revenueLow": 10086905604,
"revenueHigh": 11647139265,
"revenueAvg": 10976810907,
"ebitdaLow": 3091111951,
"ebitdaHigh": 5040402955,
"ebitdaAvg": 4020266234,
"ebitLow": 2474218387,
"ebitHigh": 4423509391,
"ebitAvg": 3403372670,
"netIncomeLow": 1957708579,
"netIncomeHigh": 3671685376,
"netIncomeAvg": 2774697360,
"sgaExpenseLow": 2481360240,
"sgaExpenseHigh": 2865174853,
"sgaExpenseAvg": 2700275309,
"epsAvg": 18.68427,
"epsHigh": 25.02853,
"epsLow": 13.34498,
"numAnalystsRevenue": 26,
"numAnalystsEps": 10
},
{
"symbol": "BIIB",
"date": "2027-12-31",
"revenueLow": 10107951733,
"revenueHigh": 11158525929,
"revenueAvg": 10668937955,
"ebitdaLow": 2881752358,
"ebitdaHigh": 4252985578,
"ebitdaAvg": 3741464101,
"ebitLow": 2182887928,
"ebitHigh": 3554121148,
"ebitAvg": 3042599671,
"netIncomeLow": 1701546905,
"netIncomeHigh": 2907247807,
"netIncomeAvg": 2457476100,
"sgaExpenseLow": 2486537549,
"sgaExpenseHigh": 2744976870,
"sgaExpenseAvg": 2624539128,
"epsAvg": 16.55066,
"epsHigh": 19.81764,
"epsLow": 11.59882,
"numAnalystsRevenue": 27,
"numAnalystsEps": 20
}
],
"price_target": {
"symbol": "BIIB",
"targetHigh": 300,
"targetLow": 175,
"targetConsensus": 245.88,
"targetMedian": 246.5
},
"ratings": {
"symbol": "BIIB",
"rating": "B",
"overallScore": 3,
"discountedCashFlowScore": 4,
"returnOnEquityScore": 3,
"returnOnAssetsScore": 4,
"debtToEquityScore": 2,
"priceToEarningsScore": 1,
"priceToBookScore": 3
},
"grades": [
{
"symbol": "BIIB",
"date": "2026-09-10",
"gradingCompany": "HSBC",
"previousGrade": "Reduce",
"newGrade": "Reduce",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-09-03",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-08-25",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-08-13",
"gradingCompany": "Wolfe Research",
"previousGrade": "Peer Perform",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2026-08-04",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-08-03",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "Wedbush",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-30",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-29",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-21",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-21",
"gradingCompany": "B of A Securities",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-13",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2026-07-08",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-06-29",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-06-18",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-06-15",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-06-08",
"gradingCompany": "Needham",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2026-05-27",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-05-15",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-05-01",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-30",
"gradingCompany": "Wedbush",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-30",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-30",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-30",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-22",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2026-04-20",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Overweight",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2026-04-14",
"gradingCompany": "Piper Sandler",
"previousGrade": "Neutral",
"newGrade": "Overweight",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2026-04-13",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-13",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-01",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-04-01",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-03-17",
"gradingCompany": "HSBC",
"previousGrade": "Reduce",
"newGrade": "Reduce",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-23",
"gradingCompany": "Freedom Broker",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-10",
"gradingCompany": "Wedbush",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Piper Sandler",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Wedbush",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-02-09",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-01-30",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-01-27",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-01-08",
"gradingCompany": "Truist Securities",
"previousGrade": "Hold",
"newGrade": "Hold",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2026-01-07",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-12-12",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-12-10",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-12-10",
"gradingCompany": "HSBC",
"previousGrade": "Hold",
"newGrade": "Reduce",
"action": "downgrade"
},
{
"symbol": "BIIB",
"date": "2025-11-21",
"gradingCompany": "Piper Sandler",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-11-06",
"gradingCompany": "Freedom Broker",
"previousGrade": "Buy",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "BIIB",
"date": "2025-11-06",
"gradingCompany": "Stifel",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "BIIB",
"date": "2025-11-03",
"gradingCompany": "Bernstein",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-10-31",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-10-14",
"gradingCompany": "Citigroup",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BIIB",
"date": "2025-10-10",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?",
"url": "https://www.zacks.com/stock/news/2996763/can-biogen-s-growth-portfolio-maintain-its-lead-over-legacy-ms-drugs?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2996763",
"source": "Zacks Investment Research",
"date": "2026-09-28 11:46:04",
"summary": "BIIB's growth products now outpace its legacy MS portfolio, with Skyclarys, Zurzuvae and newer drugs driving a shift in revenue mix.",
"image": ""
},
{
"title": "4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day",
"url": "https://www.zacks.com/stock/news/2993189/4-alzheimer-s-drug-stocks-to-watch-on-world-alzheimer-s-day?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2993189",
"source": "Zacks Investment Research",
"date": "2026-09-21 13:40:52",
"summary": "Four biotech stocks advance Alzheimer's therapies, from marketed treatments to experimental programs targeting amyloid and tau.",
"image": "https://images.financialmodelingprep.com/news/4-alzheimers-drug-stocks-to-watch-on-world-alzheimers-20260921.jpg"
},
{
"title": "Investors Dumped Ionis Pharmaceuticals Stock -- But Wall Street Hasn't Budged From Its Bullish Outlook",
"url": "https://www.fool.com/investing/2026/09/20/investors-dumped-ionis-pharmaceuticals-stock-but/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-09-20T13:30:00Z",
"summary": "Ionis Pharmaceuticals stock has plummeted over 40% this year due to late-stage clinical trial failures and ongoing losses, yet Wall Street analysts maintain a bullish outlook with an average price target of $83.82. Despite setbacks with pelacarsen and eplontersen programs, the co",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F886937%2Fadaptimmune.jpg&w=1200&op=resize"
},
{
"title": "Mesoblast (NASDAQ:MESO) and Biogen (NASDAQ:BIIB) Head-To-Head Contrast",
"url": "https://www.defenseworld.net/2026/09/18/mesoblast-nasdaqmeso-and-biogen-nasdaqbiib-head-to-head-contrast.html",
"source": "Defense World",
"date": "2026-09-18 03:18:15",
"summary": "Biogen (NASDAQ: BIIB - Get Free Report) and Mesoblast (NASDAQ: MESO - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional owners",
"image": "https://images.financialmodelingprep.com/news/mesoblast-nasdaqmeso-and-biogen-nasdaqbiib-headtohead-contrast-20260918.jpg"
},
{
"title": "Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape",
"url": "https://www.globenewswire.com/news-release/2026/09/17/3363820/28124/en/autoimmune-disease-therapeutics-market-set-for-growth-through-2034-as-biologics-precision-medicine-and-pipeline-innovation-reshape-the-competitive-landscape.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-17T10:49:00Z",
"summary": "The global autoimmune disease therapeutics market is projected to grow from USD 132.75 billion in 2025 to USD 254.60 billion by 2034, at a CAGR of 7.5%. Growth is driven by rising autoimmune disease diagnoses, increased adoption of biologics and targeted oral therapies, biosimila",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN",
"url": "https://www.globenewswire.com/news-release/2026/09/17/3364391/0/en/phase-3-pediatric-empaveli-data-published-in-clinical-journal-of-the-american-society-of-nephrology-show-reduction-in-proteinuria-and-stabilized-kidney-function-in-adolescents-with.html",
"source": "GlobeNewsWire",
"date": "2026-09-17 16:15:00",
"summary": "CAMBRIDGE, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the publication of results from a prespecified adolescent subgroup analysis of the Phase 3 VALIANT study evaluating EMPAVELI\u00ae (pegcetacoplan) in the\u00a0 Clinical Journal of the American S",
"image": "https://images.financialmodelingprep.com/news/phase-3-pediatric-empaveli-data-published-in-clinical-journal-20260917.jpg"
},
{
"title": "Corient Private Wealth LP Raises Stock Holdings in Biogen Inc. $BIIB",
"url": "https://www.defenseworld.net/2026/09/17/corient-private-wealth-lp-raises-stock-holdings-in-biogen-inc-biib.html",
"source": "Defense World",
"date": "2026-09-17 04:30:58",
"summary": "Corient Private Wealth LP raised its stake in shares of Biogen Inc. (NASDAQ: BIIB) by 14.7% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 42,397 shares of the biotechnology company's stock after acquiring an additional 5,445 shares",
"image": "https://images.financialmodelingprep.com/news/corient-private-wealth-lp-raises-stock-holdings-in-biogen-20260917.jpg"
},
{
"title": "Reviewing Fulcrum Therapeutics (NASDAQ:FULC) & Biogen (NASDAQ:BIIB)",
"url": "https://www.defenseworld.net/2026/09/17/reviewing-fulcrum-therapeutics-nasdaqfulc-biogen-nasdaqbiib.html",
"source": "Defense World",
"date": "2026-09-17 03:32:18",
"summary": "Biogen (NASDAQ: BIIB - Get Free Report) and Fulcrum Therapeutics (NASDAQ: FULC - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst ",
"image": "https://images.financialmodelingprep.com/news/reviewing-fulcrum-therapeutics-nasdaqfulc-biogen-nasdaqbiib-20260917.jpg"
},
{
"title": "LEQEMBI\u00ae Pen (Subcutaneous Formulation of LEQEMBI\u00ae) Approved in Japan for the Treatment of Early Alzheimer's Disease",
"url": "https://www.globenewswire.com/news-release/2026/09/16/3362836/0/en/leqembi-pen-subcutaneous-formulation-of-leqembi-approved-in-japan-for-the-treatment-of-early-alzheimer-s-disease.html",
"source": "GlobeNewsWire",
"date": "2026-09-16 02:00:00",
"summary": "The First and Only Anti-Amyloid Treatment in Japan that Enable At-Home Administration for Alzheimer's Disease, a Progressive Disease The First and Only Anti-Amyloid Treatment in Japan that Enable At-Home Administration for Alzheimer's Disease, a Progressive Disease",
"image": "https://images.financialmodelingprep.com/news/leqembi-pen-subcutaneous-formulation-of-leqembi-approved-in-japan-20260916.jpg"
},
{
"title": "Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics",
"url": "https://www.globenewswire.com/news-release/2026/09/15/3361815/28124/en/oligonucleotide-therapeutics-market-outlook-2026-2035-featuring-profiles-of-alnylam-pharmaceuticals-ionis-pharmaceuticals-and-sarepta-therapeutics.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-15T09:58:00Z",
"summary": "The global oligonucleotide therapeutics market is projected to grow from USD 7.7 billion in 2025 to USD 72.1 billion by 2035, expanding at a 23.4% CAGR. Growth is driven by advances in RNA-based medicine, targeted delivery technologies, expanding applications beyond rare diseases",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Hummingbird Bioscience Appoints Dr. James Garner as President",
"url": "https://www.globenewswire.com/news-release/2026/09/15/3361779/0/en/hummingbird-bioscience-appoints-dr-james-garner-as-president.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-15T09:00:00Z",
"summary": "Hummingbird Bioscience announced the appointment of Dr. James Garner as President. Garner brings over two decades of experience in drug development and commercialization from roles at Biogen, Takeda, and Sanofi, with a track record of overseeing 30+ product approvals. He previous",
"image": "https://ml.globenewswire.com/Resource/Download/c0f25a58-ceb1-4c01-b8e4-7af31894b535"
},
{
"title": "Biogen Eyes Wave of Phase III Readouts as It Expands Beyond Neuroscience",
"url": "https://www.marketbeat.com/instant-alerts/event-biogen-eyes-wave-of-phase-iii-readouts-as-it-expands-beyond-neuroscience-2026-09-14/",
"source": "MarketBeat",
"date": "2026-09-15 00:02:09",
"summary": "Biogen NASDAQ: BIIB is reshaping its business around a broader mix of neuroscience, immunology, kidney disease and ophthalmology assets, President and CEO Chris Viehbacher said during a Morgan Stanley event. The company expects a series of late-stage clinical readouts to begin as",
"image": "https://images.financialmodelingprep.com/news/biogen-eyes-wave-of-phase-iii-readouts-as-it-20260915.jpg"
},
{
"title": "Biogen Inc. (BIIB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946058-biogen-inc-biib-presents-at-morgan-stanley-24th-annual-global-healthcare-conference",
"source": "Seeking Alpha",
"date": "2026-09-14 11:21:40",
"summary": "Biogen Inc. (BIIB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/biogen-inc-biib-presents-at-morgan-stanley-24th-annual-20260914.jpg"
},
{
"title": "Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology",
"url": "https://www.marketbeat.com/instant-alerts/event-biogen-sees-pivotal-pipeline-moment-as-it-expands-beyond-neurology-2026-09-12/",
"source": "MarketBeat",
"date": "2026-09-12 17:02:21",
"summary": "Biogen NASDAQ: BIIB executives said the company is focused on diversifying beyond its historical neurology concentration, advancing a broader late-stage pipeline and managing expenses as it seeks to return to growth.",
"image": "https://images.financialmodelingprep.com/news/biogen-sees-pivotal-pipeline-moment-as-it-expands-beyond-20260912.jpg"
},
{
"title": "Biogen (NASDAQ:BIIB) versus NewAmsterdam Pharma (NASDAQ:NAMS) Financial Analysis",
"url": "https://www.defenseworld.net/2026/09/11/biogen-nasdaqbiib-versus-newamsterdam-pharma-nasdaqnams-financial-analysis.html",
"source": "Defense World",
"date": "2026-09-11 03:45:28",
"summary": "NewAmsterdam Pharma (NASDAQ: NAMS - Get Free Report) and Biogen (NASDAQ: BIIB - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recomm",
"image": "https://images.financialmodelingprep.com/news/biogen-nasdaqbiib-versus-newamsterdam-pharma-nasdaqnams-financial-analysis-20260911.jpg"
},
{
"title": "Monoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 \u2013 SNS Insider",
"url": "https://www.globenewswire.com/news-release/2026/09/09/3358267/0/en/monoclonal-antibodies-market-to-grow-at-11-01-cagr-reaching-usd-791-28-billion-by-2035-sns-insider.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-09T00:30:00Z",
"summary": "The global monoclonal antibodies market is projected to grow from USD 280.15 billion in 2025 to USD 791.28 billion by 2035, driven by increasing demand for targeted therapies in oncology, autoimmune disorders, and chronic diseases. North America leads with 41% market share, while",
"image": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2"
},
{
"title": "Biogen Inc. (BIIB) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4944444-biogen-inc-biib-presents-at-wells-fargo-21st-annual-healthcare-conference-transcript",
"source": "Seeking Alpha",
"date": "2026-09-09 15:27:04",
"summary": "Biogen Inc. (BIIB) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/biogen-inc-biib-presents-at-wells-fargo-21st-annual-20260909.jpg"
},
{
"title": "Lilly Builds Neuroscience into a New Long-Term Growth Driver",
"url": "https://www.zacks.com/stock/news/2986190/lilly-builds-neuroscience-into-a-new-long-term-growth-driver?cid=CS-ZC-FT-analyst_blog|quick_take-2986190",
"source": "Zacks Investment Research",
"date": "2026-09-08T12:27:00Z",
"summary": "Eli Lilly's neuroscience business, currently representing only 2% of revenues, is experiencing strong 32% growth with key products Kisunla and Emgality. The company is aggressively expanding its neuroscience pipeline through acquisitions including AtaiBeckley for treatment-resist",
"image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg"
},
{
"title": "Drug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider",
"url": "https://www.globenewswire.com/news-release/2026/09/07/3357068/0/en/drug-repurposing-market-to-reach-usd-50-91-billion-by-2035-expanding-at-3-93-cagr-sns-insider.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-07T10:52:00Z",
"summary": "The global drug repurposing market is projected to grow from USD 34.79 billion in 2025 to USD 50.91 billion by 2035 at a CAGR of 3.93%. North America leads with 39% market share, while Asia-Pacific shows the fastest growth at 5.02% CAGR. Small molecules dominate at 67% market sha",
"image": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2"
},
{
"title": "Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16t",
"url": "https://www.gurufocus.com/news/9067593/stoke-therapeutics-and-biogen-present-longterm-clinical-data-that-support-the-diseasemodifying-potential-of-zorevunersen-an-investigational-medicine-for-the-treatment-of-dravet-syndrome-at-the-16t",
"source": "GuruFocus",
"date": "2026-09-03 20:00:00",
"summary": "[url=\"]Stoke Therapeutics, Inc.[/url] (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with",
"image": "https://images.financialmodelingprep.com/news/stoke-therapeutics-and-biogen-present-longterm-clinical-data-that-20260903.png"
},
{
"title": "Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?",
"url": "https://www.zacks.com/stock/news/2983858/why-is-vertex-vrtx-up-14-4-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2983858",
"source": "Zacks Investment Research",
"date": "2026-09-02T15:30:12Z",
"summary": "Vertex Pharmaceuticals reported Q2 2026 earnings that missed EPS estimates ($4.73 vs $4.79 consensus) but beat revenue expectations ($3.33B vs $3.23B consensus). The company raised full-year 2026 revenue guidance to $13.10-$13.20B. However, analyst estimates have trended downward",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default202.jpg"
},
{
"title": "Canada\u2019s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI\u00ae (lecanemab) for Early Alzheimer\u2019s Disease",
"url": "https://www.globenewswire.com/news-release/2026/08/31/3353756/0/en/canada-s-drug-agency-issues-final-positive-recommendation-supporting-public-reimbursement-of-leqembi-lecanemab-for-early-alzheimer-s-disease.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-31T23:30:00Z",
"summary": "Canada's Drug Agency (CDA-AMC) has issued a final positive recommendation supporting public reimbursement of LEQEMBI (lecanemab) for patients with mild cognitive impairment or mild dementia due to early Alzheimer's disease. The recommendation follows reconsideration and will proc",
"image": "https://ml.globenewswire.com/Resource/Download/80f9c524-3da2-4583-a763-0dad931fa182"
},
{
"title": "Biogen Completes Acquisition of RayThera Inc.",
"url": "https://www.globenewswire.com/news-release/2026/08/06/3340877/0/en/Biogen-Completes-Acquisition-of-RayThera-Inc.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-06T22:15:00Z",
"summary": "Biogen Inc. announced the completion of its acquisition of RayThera Inc., a privately held biotechnology company specializing in small-molecule immunology therapies. The acquisition adds multiple assets to Biogen's immunology portfolio, with the lead program entering Phase 1 deve",
"image": "https://ml.globenewswire.com/Resource/Download/80f9c524-3da2-4583-a763-0dad931fa182"
},
{
"title": "Why Supernus Pharmaceuticals Stock Topped the Market Today",
"url": "https://www.fool.com/investing/2026/08/03/why-supernus-pharmaceuticals-stock-topped-the-mark/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-08-03T22:05:15Z",
"summary": "Supernus Pharmaceuticals announced a merger with Indivior Pharmaceuticals in an all-stock deal, creating a combined company with 11 FDA-approved drugs and anticipated $125 million in annual cost synergies. The stock rose 3% despite initial gains of 16%, reflecting cautious optimi",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F881928%2Fperson-checking-medicine-on-a-shelf-in-a-pharmacy.jpg&w=1200&op=resize"
},
{
"title": "VHT vs. PBE: Which Health Care ETF Is the Better Buy?",
"url": "https://www.fool.com/coverage/etfs/2026/07/30/vht-vs-pbe-which-health-care-etf-is-the-better-buy/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-07-30T13:09:49Z",
"summary": "The Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 423 holdings, while the Invesco Biotechnology & Genome ETF (PBE) provides focused biotech exposure with 31 holdings and higher growth potential. PBE delivered a stronger 40.88% ",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F4db1f9dc6b521047b90577456a50b49560e87c49-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
}
]
Data:
[
{
"symbol": "BIIB",
"date": "2026-10-28",
"epsActual": null,
"epsEstimated": 2.03,
"revenueActual": null,
"revenueEstimated": 2637872000,
"lastUpdated": "2026-09-29"
},
{
"symbol": "BIIB",
"date": "2026-07-29",
"epsActual": 3.6,
"epsEstimated": 2.94,
"revenueActual": 2736000000,
"revenueEstimated": 2460437000,
"lastUpdated": "2026-09-29"
},
{
"symbol": "BIIB",
"date": "2026-04-29",
"epsActual": 3.57,
"epsEstimated": 3.05,
"revenueActual": 2477800000,
"revenueEstimated": 2286827000,
"lastUpdated": "2026-07-29"
},
{
"symbol": "BIIB",
"date": "2026-02-06",
"epsActual": 1.99,
"epsEstimated": 1.63,
"revenueActual": 2279400000,
"revenueEstimated": 2202677000,
"lastUpdated": "2026-05-06"
},
{
"symbol": "BIIB",
"date": "2025-10-30",
"epsActual": 4.81,
"epsEstimated": 3.88,
"revenueActual": 2454800000,
"revenueEstimated": 2340021835,
"lastUpdated": "2026-01-30"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "BIIB",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "BIIB",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 2785,
"price": 216.63
},
{
"file_period": "202607b",
"settlement_date": "20260717",
"quantity_fails": 8,
"price": 208.92
},
{
"file_period": "202608a",
"settlement_date": "20260807",
"quantity_fails": 135,
"price": 206.28
},
{
"file_period": "202608b",
"settlement_date": "20260828",
"quantity_fails": 991,
"price": 221.5
},
{
"file_period": "202609a",
"settlement_date": "20260914",
"quantity_fails": 416,
"price": 217.15
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "BIIB",
"filingDate": "2026-09-03",
"transactionDate": "2026-09-01",
"reportingCik": "0001661567",
"companyCik": "0000875045",
"transactionType": "A-Award",
"securitiesOwned": 7405,
"reportingName": "Parini Michael",
"typeOfOwner": "officer: Chief Legal Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7405,
"price": 0,
"securityName": "Restricted Stock Unit",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000082/0000875045-26-000082-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-03",
"reportingCik": "0001661567",
"companyCik": "0000875045",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Parini Michael",
"typeOfOwner": "officer",
"acquisitionOrDisposition": "",
"directOrIndirect": null,
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000080/0000875045-26-000080-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-08-05",
"transactionDate": "2026-08-03",
"reportingCik": "0002038687",
"companyCik": "0000875045",
"transactionType": "S-Sale",
"securitiesOwned": 3282,
"reportingName": "Minor Lloyd",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 593,
"price": 203.34,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000076/0000875045-26-000076-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-08-05",
"transactionDate": "2026-08-04",
"reportingCik": "0002038687",
"companyCik": "0000875045",
"transactionType": "S-Sale",
"securitiesOwned": 2689,
"reportingName": "Minor Lloyd",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 593,
"price": 200.96,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000076/0000875045-26-000076-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-06-11",
"transactionDate": "2026-06-09",
"reportingCik": "0001106508",
"companyCik": "0000875045",
"transactionType": "A-Award",
"securitiesOwned": 10365,
"reportingName": "HAWKINS WILLIAM A",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1505,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000065/0000875045-26-000065-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-06-11",
"transactionDate": "2026-06-09",
"reportingCik": "0001079462",
"companyCik": "0000875045",
"transactionType": "A-Award",
"securitiesOwned": 15193,
"reportingName": "SHERWIN STEPHEN A",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1505,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000064/0000875045-26-000064-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-06-11",
"transactionDate": "2026-06-09",
"reportingCik": "0001318886",
"companyCik": "0000875045",
"transactionType": "A-Award",
"securitiesOwned": 25844,
"reportingName": "Rowinsky Eric K",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1505,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000063/0000875045-26-000063-index.htm"
},
{
"symbol": "BIIB",
"filingDate": "2026-06-11",
"transactionDate": "2026-06-09",
"reportingCik": "0001777331",
"companyCik": "0000875045",
"transactionType": "A-Award",
"securitiesOwned": 11263,
"reportingName": "Mantas Jesus B",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1505,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000062/0000875045-26-000062-index.htm"
}
],
"congress": [
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2019-04-17",
"transactionDate": "2019-03-22",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Spouse",
"assetDescription": "Biogen Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/94008f80-fd16-4656-afb6-ba4ae1d47319/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2018-02-13",
"transactionDate": "2018-01-08",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Joint",
"assetDescription": "Biogen Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/1f92054e-7799-4438-a50c-dc4930429f4f/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2017-01-11",
"transactionDate": "2016-12-23",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Joint",
"assetDescription": "Biogen Inc.",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/217dbf6f-8941-4967-94d3-22bf039e1d30/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2017-01-11",
"transactionDate": "2016-12-13",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/217dbf6f-8941-4967-94d3-22bf039e1d30/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2016-08-11",
"transactionDate": "2015-08-10",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/24deb6c7-36d1-4688-96ec-8116e867d18f/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2016-08-11",
"transactionDate": "2015-08-04",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/24deb6c7-36d1-4688-96ec-8116e867d18f/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2016-08-11",
"transactionDate": "2015-08-04",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Spouse",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/24deb6c7-36d1-4688-96ec-8116e867d18f/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2016-08-11",
"transactionDate": "2015-08-10",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Joint",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/24deb6c7-36d1-4688-96ec-8116e867d18f/"
},
{
"symbol": "BIIB",
"senateID": "I000024",
"disclosureDate": "2016-08-04",
"transactionDate": "2016-07-21",
"firstName": "James Mountain",
"lastName": "Inhofe",
"office": "James M Inhofe",
"district": "OK",
"owner": "Self",
"assetDescription": "Biogen Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$50,001 - $100,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/a01f47de-3ccf-4693-b6c0-39c0b29acf3d/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-09-24",
"transactionDate": "2015-08-28",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Joint",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/aa249ce3-6a83-4bb8-a1b6-80fc2a1c2fef/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-09-01",
"transactionDate": "2015-08-10",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/24a82dfc-b32a-4ec8-b78c-f72ec81f32d1/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-09-01",
"transactionDate": "2015-08-04",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/24a82dfc-b32a-4ec8-b78c-f72ec81f32d1/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-09-01",
"transactionDate": "2015-08-04",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Spouse",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/24a82dfc-b32a-4ec8-b78c-f72ec81f32d1/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-09-01",
"transactionDate": "2015-08-10",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Joint",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/24a82dfc-b32a-4ec8-b78c-f72ec81f32d1/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-08-12",
"transactionDate": "2015-05-07",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/9cc0fe86-0656-415d-936a-dd4259c51b54/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-07-21",
"transactionDate": "2015-07-10",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/bc98ba42-c220-473c-9b6a-218ab3f54776/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-07-21",
"transactionDate": "2015-07-10",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Joint",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/bc98ba42-c220-473c-9b6a-218ab3f54776/"
},
{
"symbol": "BIIB",
"senateID": "C001035",
"disclosureDate": "2015-07-20",
"transactionDate": "2014-07-23",
"firstName": "Susan Margaret",
"lastName": "Collins",
"office": "Susan M. Collins",
"district": "ME",
"owner": "Spouse",
"assetDescription": "Biogen Idec Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/9f9dbfa0-c403-4c71-b9ae-90225aed470f/"
},
{
"symbol": "BIIB",
"senateID": "I000024",
"disclosureDate": "2015-07-15",
"transactionDate": "2015-07-09",
"firstName": "James Mountain",
"lastName": "Inhofe",
"office": "James M Inhofe",
"district": "OK",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/19829594-5717-4584-9c23-352c638d83b3/"
},
{
"symbol": "BIIB",
"senateID": "W000802",
"disclosureDate": "2015-06-03",
"transactionDate": "2015-05-07",
"firstName": "Sheldon",
"lastName": "Whitehouse",
"office": "Sheldon Whitehouse",
"district": "RI",
"owner": "Self",
"assetDescription": "Biogen Inc. (NASDAQ)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/d16a03dd-c7ee-4bf8-b760-bccb5d5677c2/"
},
{
"symbol": "BIIB",
"senateID": "H001082",
"disclosureDate": "2026-09-02",
"transactionDate": "2026-08-18",
"firstName": "Kevin",
"lastName": "Hern",
"office": "Kevin Hern",
"district": "OK01",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035326.pdf"
},
{
"symbol": "BIIB",
"senateID": "S000168",
"disclosureDate": "2026-07-08",
"transactionDate": "2026-06-02",
"firstName": "Maria Elvira",
"lastName": "Salazar",
"office": "Maria Elvira Salazar",
"district": "FL27",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034928.pdf"
},
{
"symbol": "BIIB",
"senateID": "C001123",
"disclosureDate": "2026-07-03",
"transactionDate": "2026-06-05",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034906.pdf"
},
{
"symbol": "BIIB",
"senateID": "S000168",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-11",
"firstName": "Maria Elvira",
"lastName": "Salazar",
"office": "Maria Elvira Salazar",
"district": "FL27",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034709.pdf"
},
{
"symbol": "BIIB",
"senateID": "S000168",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-11",
"firstName": "Maria Elvira",
"lastName": "Salazar",
"office": "Maria Elvira Salazar",
"district": "FL27",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$50,001 - $100,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034709.pdf"
},
{
"symbol": "BIIB",
"senateID": "S000168",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-12",
"firstName": "Maria Elvira",
"lastName": "Salazar",
"office": "Maria Elvira Salazar",
"district": "FL27",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034709.pdf"
},
{
"symbol": "BIIB",
"senateID": "C001123",
"disclosureDate": "2026-02-13",
"transactionDate": "2026-01-30",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20033983.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2025-09-12",
"transactionDate": "2025-08-26",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/9115642.pdf"
},
{
"symbol": "BIIB",
"senateID": "B001327",
"disclosureDate": "2025-06-10",
"transactionDate": "2025-05-15",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030482.pdf"
},
{
"symbol": "BIIB",
"senateID": "B001327",
"disclosureDate": "2025-05-08",
"transactionDate": "2025-04-08",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030291.pdf"
},
{
"symbol": "BIIB",
"senateID": "B001327",
"disclosureDate": "2025-03-28",
"transactionDate": "2025-02-25",
"firstName": "Robert P.",
"lastName": "Bresnahan",
"office": "Rob Bresnahan",
"district": "PA08",
"owner": "",
"assetDescription": "Biogen Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029034.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-12-06",
"transactionDate": "2024-11-15",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220691.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-10-08",
"transactionDate": "2024-09-09",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220660.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-10-08",
"transactionDate": "2024-09-09",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220660.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-04-05",
"transactionDate": "2024-03-20",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220192.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-04-05",
"transactionDate": "2024-03-25",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220192.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-03-06",
"transactionDate": "2024-02-13",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220173.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2024-02-05",
"transactionDate": "2024-01-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/8220127.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2023-12-06",
"transactionDate": "2023-11-03",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220067.pdf"
},
{
"symbol": "BIIB",
"senateID": "K000389",
"disclosureDate": "2023-11-08",
"transactionDate": "2023-10-02",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biogen Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8220039.pdf"
}
],
"dark_pool": [
{
"ticker": "BIIB",
"executed_at": "2026-09-29T21:21:37.410000Z",
"size": 36003.0,
"price": 227.07,
"premium": 8175201.21,
"volume": 36003.0,
"trade_code": " "
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:00:18.626000Z",
"size": 35000.0,
"price": 227.07,
"premium": 7947450.0,
"volume": 35000.0,
"trade_code": " "
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:00:01.541000Z",
"size": 33908.0,
"price": 227.07,
"premium": 7699489.56,
"volume": 33908.0,
"trade_code": "6"
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:00:01.541000Z",
"size": 24800.0,
"price": 227.07,
"premium": 5631336.0,
"volume": 24800.0,
"trade_code": "6"
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:16:00.582000Z",
"size": 23181.0,
"price": 226.7717,
"premium": 5256794.7777,
"volume": 23181.0,
"trade_code": " "
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:00:01.541000Z",
"size": 21360.0,
"price": 227.07,
"premium": 4850215.2,
"volume": 21360.0,
"trade_code": "6"
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:00:23.095000Z",
"size": 6608.0,
"price": 227.07,
"premium": 1500478.56,
"volume": 6608.0,
"trade_code": " "
},
{
"ticker": "BIIB",
"executed_at": "2026-09-29T20:00:01.541000Z",
"size": 3699.0,
"price": 227.07,
"premium": 839931.9299999999,
"volume": 3699.0,
"trade_code": "6"
}
],
"ats": {
"symbol": "BIIB",
"date": "20260928",
"ats_volume": 0,
"total_volume": 501596,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260928",
"ats_ratio": 0.0
},
{
"date": "20260925",
"ats_ratio": 0.0
},
{
"date": "20260924",
"ats_ratio": 0.0
},
{
"date": "20260923",
"ats_ratio": 0.0
},
{
"date": "20260922",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "BIIB",
"days": [
{
"date": "2026-09-29",
"close": 227.07,
"vwap": 226.8,
"volume": 1161174,
"vwap_discount_pct": -0.12
},
{
"date": "2026-09-28",
"close": 228.69,
"vwap": 228.62,
"volume": 1332340,
"vwap_discount_pct": -0.03
},
{
"date": "2026-09-25",
"close": 227.6,
"vwap": 226.98,
"volume": 958030,
"vwap_discount_pct": -0.27
},
{
"date": "2026-09-24",
"close": 226.36,
"vwap": 226.71,
"volume": 1034741,
"vwap_discount_pct": 0.15
},
{
"date": "2026-09-23",
"close": 227.53,
"vwap": 226.39,
"volume": 1494492,
"vwap_discount_pct": -0.5
}
],
"avg_vwap_discount_pct": -0.15,
"signal": "Neutral"
},
"options_flow": [
{
"nbbo_bid": "14.70",
"strike": "220",
"volume": 33,
"underlying_symbol": "BIIB",
"option_chain_id": "BIIB261106C00220000",
"size": 15,
"underlying_price": "226.46",
"open_interest": 0,
"expiry": "2026-11-06",
"delta": "0.623107431254194",
"sector": "Healthcare",
"price": "16.10",
"nbbo_ask": "17.50",
"implied_volatility": "0.4198355630187499",
"premium": "24150.00",
"executed_at": "2026-09-29T14:05:02.428000Z",
"option_type": "call"
},
{
"nbbo_bid": "100.00",
"strike": "155",
"volume": 2,
"underlying_symbol": "BIIB",
"option_chain_id": "BIIB290119C00155000",
"size": 2,
"underlying_price": "224.855",
"open_interest": 0,
"expiry": "2029-01-19",
"delta": "0.86175775933622",
"sector": "Healthcare",
"price": "100.00",
"nbbo_ask": "102.50",
"implied_volatility": "0.4124209091116721",
"premium": "20000.00",
"executed_at": "2026-09-29T14:39:45.350000Z",
"option_type": "call"
},
{
"nbbo_bid": "75.30",
"strike": "150",
"volume": 2,
"underlying_symbol": "BIIB",
"option_chain_id": "BIIB261218C00150000",
"size": 2,
"underlying_price": "224.855",
"open_interest": 14,
"expiry": "2026-12-18",
"delta": "0.970749080210307",
"sector": "Healthcare",
"price": "76.90",
"nbbo_ask": "76.90",
"implied_volatility": "0.498369115189088",
"premium": "15380.00",
"executed_at": "2026-09-29T14:39:45.350000Z",
"option_type": "call"
},
{
"nbbo_bid": "7.10",
"strike": "235",
"volume": 15,
"underlying_symbol": "BIIB",
"option_chain_id": "BIIB261106C00235000",
"size": 15,
"underlying_price": "226.46",
"open_interest": 0,
"expiry": "2026-11-06",
"delta": "0.4256661841439259",
"sector": "Healthcare",
"price": "8.50",
"nbbo_ask": "9.90",
"implied_volatility": "0.4012408980076259",
"premium": "12750.00",
"executed_at": "2026-09-29T14:05:02.428000Z",
"option_type": "call"
}
],
"net_premium": {
"ticker": "BIIB",
"net_call_premium": "-74204.00",
"net_put_premium": "6427.00",
"call_premium": "363761.00",
"put_premium": "44604.00",
"bullish_premium": "124592.00",
"bearish_premium": "205223.00",
"put_call_ratio": "0.3409090909090909090909090909",
"iv_rank": "49.0932",
"implied_move_perc": "0.074",
"gex_ratio": "0.36748283731223732393",
"gex_net_change": "356.3272",
"gex_call": "15557.5619",
"gex_put": "-5406.8337",
"gex_net": 10150.7282,
"gex_call_delta": "1251219.7830",
"gex_put_delta": "-169725.1542",
"gex_date": "2026-09-29"
},
"hot_chains": [
{
"underlying_symbol": "BIIB",
"expires": "2026-11-06",
"open_interest": 0,
"option_type": "call",
"delta": 0.620076868977092,
"ask_volume": 15,
"last_price": "15.55",
"implied_volatility": "0.3863611691500948",
"gamma": 0.0127816413285491,
"avg_price": "15.822500000000000000000000000",
"bid_volume": 15,
"nbbo_ask": "16.30",
"strike": "220",
"option_symbol": "BIIB261106C00220000",
"total_premium": "82277.00",
"iv": 0.406388713242767,
"volume": 52,
"nbbo_bid": "14.60"
},
{
"underlying_symbol": "BIIB",
"expires": "2026-11-06",
"open_interest": 0,
"option_type": "call",
"delta": 0.347182636251484,
"ask_volume": 13,
"last_price": "6.08",
"implied_volatility": "0.3683829258998965",
"gamma": 0.0133047598057457,
"avg_price": "6.1600000000000000000000000002",
"bid_volume": 16,
"nbbo_ask": "6.70",
"strike": "240",
"option_symbol": "BIIB261106C00240000",
"total_premium": "25256.00",
"iv": 0.378690388980552,
"volume": 41,
"nbbo_bid": "5.40"
},
{
"underlying_symbol": "BIIB",
"expires": "2027-03-19",
"open_interest": 30,
"option_type": "call",
"delta": 0.108876418406588,
"ask_volume": 29,
"last_price": "2.20",
"implied_volatility": "0.3433246985812276",
"gamma": 0.00325501786924858,
"avg_price": "2.2575757575757575757575757575",
"bid_volume": 4,
"nbbo_ask": "4.60",
"strike": "320",
"option_symbol": "BIIB270319C00320000",
"total_premium": "7450.00",
"iv": 0.369002187139718,
"volume": 33,
"nbbo_bid": "1.05"
},
{
"underlying_symbol": "BIIB",
"expires": "2027-04-16",
"open_interest": 18,
"option_type": "call",
"delta": 0.602141415403575,
"ask_volume": 6,
"last_price": "31.80",
"implied_volatility": "0.389496350954447",
"gamma": 0.00527113829067487,
"avg_price": "31.888181818181818181818181817",
"bid_volume": 14,
"nbbo_ask": "34.00",
"strike": "220",
"option_symbol": "BIIB270416C00220000",
"total_premium": "70154.00",
"iv": 0.43658380270701,
"volume": 22,
"nbbo_bid": "30.40"
},
{
"underlying_symbol": "BIIB",
"expires": "2026-11-06",
"open_interest": 0,
"option_type": "call",
"delta": 0.418466365961125,
"ask_volume": 0,
"last_price": "7.70",
"implied_volatility": "0.3645219040831689",
"gamma": 0.0134644118638632,
"avg_price": "8.338888888888888888888888889",
"bid_volume": 1,
"nbbo_ask": "9.90",
"strike": "235",
"option_symbol": "BIIB261106C00235000",
"total_premium": "15010.00",
"iv": 0.395760915856037,
"volume": 18,
"nbbo_bid": "6.70"
},
{
"underlying_symbol": "BIIB",
"expires": "2026-10-16",
"open_interest": 338,
"option_type": "call",
"delta": 0.446821451610101,
"ask_volume": 2,
"last_price": "4.78",
"implied_volatility": "0.2981188354258018",
"gamma": 0.023053359898779,
"avg_price": "4.4376470588235294117647058824",
"bid_volume": 15,
"nbbo_ask": "7.20",
"strike": "230",
"option_symbol": "BIIB261016C00230000",
"total_premium": "7544.00",
"iv": 0.350027231640606,
"volume": 17,
"nbbo_bid": "4.30"
},
{
"underlying_symbol": "BIIB",
"expires": "2026-10-02",
"open_interest": 14,
"option_type": "put",
"delta": -0.281652636279783,
"ask_volume": 2,
"last_price": "1.27",
"implied_volatility": "0.3748435263497073",
"gamma": 0.0412151122981984,
"avg_price": "1.3807692307692307692307692308",
"bid_volume": 11,
"nbbo_ask": "2.55",
"strike": "222.5",
"option_symbol": "BIIB261002P00222500",
"total_premium": "1795.00",
"iv": 0.397867030089483,
"volume": 13,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "BIIB",
"expires": "2026-10-09",
"open_interest": 13,
"option_type": "call",
"delta": 0.426188371004938,
"ask_volume": 0,
"last_price": "2.88",
"implied_volatility": "0.2999835812177804",
"gamma": 0.0288066890185967,
"avg_price": "2.8800000000000000000000000000",
"bid_volume": 12,
"nbbo_ask": "5.50",
"strike": "230",
"option_symbol": "BIIB261009C00230000",
"total_premium": "3456.00",
"iv": 0.36217682650974,
"volume": 12,
"nbbo_bid": "2.80"
}
],
"gamma_profile": {
"ticker": "BIIB",
"spot": 227.07,
"date": "2026-09-29",
"flip_point": 219.94,
"net_gex": 10150.73,
"call_walls": [
{
"strike": 230.0,
"gex": 3087.14
},
{
"strike": 250.0,
"gex": 2361.33
},
{
"strike": 240.0,
"gex": 1794.56
}
],
"put_walls": [
{
"strike": 200.0,
"gex": -892.99
},
{
"strike": 210.0,
"gex": -843.79
},
{
"strike": 220.0,
"gex": -797.46
}
],
"by_strike": [
{
"strike": 197.5,
"call_gex": 0.41,
"put_gex": -0.11,
"net_gex": 0.3
},
{
"strike": 200.0,
"call_gex": 824.11,
"put_gex": -892.99,
"net_gex": -68.88
},
{
"strike": 202.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 205.0,
"call_gex": 99.43,
"put_gex": -78.05,
"net_gex": 21.38
},
{
"strike": 207.5,
"call_gex": 0.0,
"put_gex": -0.99,
"net_gex": -0.99
},
{
"strike": 210.0,
"call_gex": 972.47,
"put_gex": -843.79,
"net_gex": 128.68
},
{
"strike": 212.5,
"call_gex": 0.71,
"put_gex": -6.52,
"net_gex": -5.81
},
{
"strike": 215.0,
"call_gex": 139.02,
"put_gex": -33.86,
"net_gex": 105.16
},
{
"strike": 217.5,
"call_gex": 12.8,
"put_gex": -9.58,
"net_gex": 3.22
},
{
"strike": 220.0,
"call_gex": 1218.4,
"put_gex": -797.46,
"net_gex": 420.94
},
{
"strike": 222.5,
"call_gex": 54.36,
"put_gex": -50.39,
"net_gex": 3.98
},
{
"strike": 225.0,
"call_gex": 355.22,
"put_gex": -115.19,
"net_gex": 240.03
},
{
"strike": 227.5,
"call_gex": 214.18,
"put_gex": -29.27,
"net_gex": 184.91
},
{
"strike": 230.0,
"call_gex": 3087.14,
"put_gex": -328.09,
"net_gex": 2759.05
},
{
"strike": 232.5,
"call_gex": 391.48,
"put_gex": 0.0,
"net_gex": 391.48
},
{
"strike": 235.0,
"call_gex": 433.62,
"put_gex": -4.54,
"net_gex": 429.08
},
{
"strike": 237.5,
"call_gex": 48.11,
"put_gex": 0.0,
"net_gex": 48.11
},
{
"strike": 240.0,
"call_gex": 1794.56,
"put_gex": -26.5,
"net_gex": 1768.07
},
{
"strike": 242.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 245.0,
"call_gex": 448.28,
"put_gex": 0.0,
"net_gex": 448.28
},
{
"strike": 247.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 250.0,
"call_gex": 2361.33,
"put_gex": -4.2,
"net_gex": 2357.14
},
{
"strike": 255.0,
"call_gex": 173.92,
"put_gex": 0.0,
"net_gex": 173.92
},
{
"strike": 260.0,
"call_gex": 443.05,
"put_gex": -8.96,
"net_gex": 434.1
},
{
"strike": 265.0,
"call_gex": 43.51,
"put_gex": 0.0,
"net_gex": 43.51
}
]
},
"oi_changes": {
"net_call_oi_change": -194,
"net_put_oi_change": 0,
"top": [
{
"strike": "230",
"oi_change": -200,
"type": "call"
},
{
"strike": "250",
"oi_change": 3,
"type": "call"
},
{
"strike": "210",
"oi_change": 2,
"type": "call"
},
{
"strike": "200",
"oi_change": 1,
"type": "call"
},
{
"strike": "150",
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": -9.7,
"D": -19.5,
"P": 46.0,
"O": 7.0,
"C": 49.6,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.85,
"ranked": true,
"components": {
"M": 26.6,
"T": 60.6,
"RS": 89.4,
"V": 18.5,
"F": 39.5,
"OI": -100.0,
"S": 0.6,
"IV": 100.0,
"B": null,
"Liquidity": 2.6,
"OpeningConfidence": 78.7,
"FlowAgreement": 75.0,
"StrikeBreadth": 66.7
},
"drivers": [
"- open-interest change -100",
"+ IV behaviour +100",
"+ relative strength +89",
"+ trend +61",
"+ aggressive flow +40"
]
}
}
Data:
{
"vix": 15.67,
"sp500": 7743.41,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.36,
"hy_spread": 2.8,
"treasury": {
"date": "2026-09-25",
"month1": 4.04,
"month2": 4.2,
"month3": 4.24,
"month6": 4.33,
"year1": 4.5,
"year2": 4.81,
"year3": 4.94,
"year5": 4.98,
"year7": 5.06,
"year10": 5.17,
"year20": 5.54,
"year30": 5.49
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.2%",
"actual": null,
"minutes_until": 737
},
{
"title": "Final GDP q/q",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": 737
},
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 3617
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "90K",
"previous": "162K",
"actual": null,
"minutes_until": 3617
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 3617
}
]
}
Data:
{
"days": 103,
"patterns": [
{
"name": "ORB Breakout",
"count": 103,
"pct": 100
},
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 97,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 93,
"pct": 90
},
{
"name": "Open Retracement",
"count": 79,
"pct": 77
},
{
"name": "Gap Fill",
"count": 73,
"pct": 71
},
{
"name": "Darvas Box",
"count": 48,
"pct": 47
},
{
"name": "High Vol Open",
"count": 24,
"pct": 23
},
{
"name": "Power Hour",
"count": 20,
"pct": 19
}
]
}